Serum calcium in bronchial carcinoma: a population-based study

Area of Science:

• Oncology
• Medical Biochemistry

Background:

• Bronchial carcinoma is a significant cause of cancer-related mortality.
• Hypercalcemia is a known complication of various malignancies, but its prevalence and impact in bronchial carcinoma require further elucidation.

Purpose of the Study:

• To investigate the incidence and clinical significance of hypercalcemia in patients with bronchial carcinoma.
• To determine the association between serum calcium levels and survival outcomes in this patient cohort.

Main Methods:

• Serum calcium levels were measured in 245 patients with bronchial carcinoma and compared to a control group.
• Hypercalcemia was defined as serum calcium greater than or equal to 2.60 mmol/l.
• Survival analysis was performed based on initial serum calcium levels.

Main Results:

• 25% of bronchial carcinoma patients presented with hypercalcemia, compared to 16% in controls (p<0.01).
• Squamous cell carcinoma was the most frequent histological type associated with hypercalcemia.
• A total of 38% of patients developed hypercalcemia during the disease course.
• Patients with serum calcium above 2.68 mmol/l on admission had significantly shorter survival.

Conclusions:

• Hypercalcemia is a frequent complication of bronchial carcinoma, observed in 38% of patients over time.
• The presence of hypercalcemia at diagnosis is associated with poorer survival outcomes.
• Hypercalcemia management may be an important factor in improving the prognosis of bronchial carcinoma.